Viewing Study NCT04166006

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 5:24 PM
Ignite Modification Date: 2026-01-09 @ 11:16 PM
Study NCT ID: NCT04166006
Status: RECRUITING
Last Update Posted: 2024-09-19
First Post: 2019-11-14
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase II Study on Adjuvant Vaccination with Dendritic Cells Loaded with Autologous Tumor Homogenate in Resected Stage IV Rare Cancers.
Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Head Neck Tumors View
None Neuroendocrine Tumors View
None Soft Tissue Sarcoma View
None Rare Cancer View
None Vaccination View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Head Neck Tumors View
None Neuroendocrine Tumors View
None Soft Tissue Sarcoma View
None rare cancer View
None vaccination View
None autologous dendritic cells View
None adjuvant View
None Interleukin-2 View